Hepcidin: A useful marker in chronic obstructive pulmonary disease

Annals of Thoracic Medicine

Volumn 7, Issue 1, 2012, Pages 31-35

  Duru, Serap ^a   Bilgin, Esra ^b   Ardiç, Sadik ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Dr Ali Menekse Chest Diseases Hospital   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; hepcidin; hypoxemia

Indexed keywords

FERRITIN; HEMOGLOBIN; HEPCIDIN; IRON;

ADULT; AGE; AGED; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MARKER; FERRITIN BLOOD LEVEL; HEMATOCRIT; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SMOKING;

EID: 84856589321     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.91562     Document Type: Article

References (26)

1. Global strategy for agnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2009. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Scientific Committe. Available from: http://www.goldcopd.org. [Last accessed on 2011 June 9].
2. WHO (World Health Organization). World Health Statistics 2008 Available from: http://www.who.int/topics/chronic-obstructive-pulmonary-disease/en/[Last accessed on 2011 June 9].
3. Agusti A, Thomas a, Neff lecture: Chronic obstructive pulmonary disease-a systemic disease. Proc Am Thorac Soc 2006;3:478-81. (Pubitemid 44285523)
4. Kawakami Y, Kishi F, Yamamoto H, Miyamoto K. Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary disease. N Engl J Med 1983; 308:1405-7.
5. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthsized in the liver. J Biol Chem 2001;276:7806-10.
6. Kemna EH, Tjalsma H, Willems HL, Swinkles DW. Hepcidin: From discovery to differential diagnosis. Haematologica 2008;93:90-7. (Pubitemid 351156156)
7. Ganz T, Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 2006;1763:690-9. (Pubitemid 44189542)
8. Nemeth E, Rivera S, Gabayan V. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6. (Pubitemid 39069926)
9. Kemna E, Pickkers P, Nemeth E, Van Der Hoeven H. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106:1864-6. (Pubitemid 41208606)
10. Nemeth E, Valore EV, Territo M, Schiller G. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 2003;101:2461-3. (Pubitemid 36857598)
11. Nicolas G. The gene encoding then iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-44.
12. Sharma S, Nemeth E, Chen YH. Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res 2008;14:3262-7.
13. Lauta VM. A review of the cytokine network in multiple myeloma: Diagnostic, prognostic, and therapeutic implications. Cancer 2003;97:2440-52. (Pubitemid 36542483)
14. Tomosugi N, Kabawata H, Wakatabe R. Detection of serum hepcidin in renal failure and inflammation by using Protein Chip System. Blood 2006;108:1381-87. (Pubitemid 44232041)
15. Frazier MD, Mamo LB, Ghio AJ, Turi JL. Hepcidin expression in human airway epithelial cells is regulated by interferon-gamma. Respir Res 2011:12;100.
16. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: A role in host defense against tuberculosis. J Leukoc Biol 2007:82;934-45. (Pubitemid 47511054)
17. Kim HR, Kim KW, Yoon SY, Kim SH, Lee SH. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis. J Korean Med Sci 2010:25;348-52.
18. Koca SS, Isik A, Ustundag B, Metin K, Aksoy K. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 2008:31;146-53.
19. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005;18:171-82. (Pubitemid 40298363)
20. Prescott E, Almdal T, Mikkelsen KL. Prognostic value of weight change in chronic obstructive pulmonary disease: Results from the Copenhagen City Heart Study. Eur Respir J 2002;20:539-44.
21. Lanbo C, Prescott E, Lange P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61. (Pubitemid 30004687)
22. Eid AA, Ionescu AA, Nixon LS. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-8. (Pubitemid 33124019)
23. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest. 2002;121(5 Suppl):127-30.
24. Amato A, Santoro N, Calobro P. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes 2010;34:1772-4.
25. Aeberli I, Hurell R. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes 2009;33:1111-7.
26. Tussing-Humphreys LM, Nemeth E, Fantuzzi G. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity 2010;18:1449-56.